Loading...
Tocilizumab treatment in COVID‐19: A single center experience
Tocilizumab (TCZ), a monoclonal antibody against interleukin‐6 (IL‐6), emerged as an alternative treatment for COVID‐19 patients with a risk of cytokine storms recently. In the present study, we aimed to discuss the treatment response of TCZ therapy in COVID‐19 infected patients. The demographic, tr...
Na minha lista:
| Udgivet i: | J Med Virol |
|---|---|
| Main Authors: | , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
John Wiley and Sons Inc.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7262125/ https://ncbi.nlm.nih.gov/pubmed/32253759 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jmv.25801 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|